Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Huangjing Yangji Formula Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcopenia
1 trial -
Immunosuppressive therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
In-stent Restenosis Lesion
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
Hospital Authority, Hong Kong
CD30+ Peripheral T-cell Lymphoma
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
The First People's Hospital of Lianyungang
CD30+ Peripheral T-cell Lymphoma
1 trial -
Intestinal Microbiota Transplant (IMT) Capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Intravenous Anesthetic Induction with Ciprofol for Painless Colonoscopy in Elderly Patients
The First People's Hospital of Lianyungang
Ciprofol
1 trial -
Ixekizumab+Jueyin Granules
Universal Integrated
Plaque Psoriasis
1 trial -
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
NBP Softgel Capsules
The First People's Hospital of Lianyungang
Migraine
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Shenbai Granules
The First People's Hospital of Lianyungang
Colorectal Adenoma
1 trial -
Sivelestat
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Sivelestat sodium
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Thoracic Paravertebral Block with Local Anesthetic
The First People's Hospital of Lianyungang
Pulmonary Nodules
1 trial -
Total glucosides of paeony & Acitretin Capsules
The First People's Hospital of Lianyungang
Psoriasis
1 trial -
Xiangsha Liujunzi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Functional Dyspepsia
1 trial -
Yin and Yang tonic granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteopenia
1 trial -
Yishen Qutong Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
probiotic cocktail capsules
Hospital Authority, Hong Kong
Vancomycin-Resistant Enterococci
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources